The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Künzel, Associate Director in the Functional Genomics department at AstraZeneca, about the application of arrayed ...
The University of California Berkeley and UC San Francisco announced this week the launch of the Laboratory for Genomics Research, in which scientists from both institutions will use CRISPR gene ...
Higher yields, greater resilience to climatic changes or diseases—the demands on crop plants are constantly growing. To ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
New partnership network combines the power of automated CRISPR cell line engineering with phenotypic, functional and multi-omic assays to optimize research workflows. Synthego launches CRISPR ...
Third Rock Ventures has launched a new cancer drug discovery and development company, Tango Therapeutics, with a $55 million Series A investment. The new firm, based in Cambridge, MA, is exploiting a ...
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to ...